Controversias en tromboembolismo pulmonar masivo

Massive pulmonary embolism (PE) is associated with high mortality. There is still a broad assortment of severity classifications for patients with PE, which affects the choice of therapies to use. The main clinical criteria for defining a PE as massive is systemic arterial hypotension, which depends on the extent of vascular obstruction and the previous cardiopulmonary status. Right ventricular dysfunction is an important pathogenic element to define the severity of patients and short term clinical prognosis. The recommended treatment is systemic thrombolysis, but in centers with experience and resources, radiological invasive therapies through catheters are useful alternatives that can be used as first choice tools in certain cases.

Saved in:
Bibliographic Details
Main Authors: Mercado,Marcelo, Aizman,Andrés, Andresen,Max
Format: Digital revista
Language:Spanish / Castilian
Published: Sociedad Médica de Santiago 2013
Online Access:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872013000400010
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0034-98872013000400010
record_format ojs
spelling oai:scielo:S0034-988720130004000102013-09-11Controversias en tromboembolismo pulmonar masivoMercado,MarceloAizman,AndrésAndresen,Max Pulmonary embolism Thrombectomy Thrombolytic therapy Massive pulmonary embolism (PE) is associated with high mortality. There is still a broad assortment of severity classifications for patients with PE, which affects the choice of therapies to use. The main clinical criteria for defining a PE as massive is systemic arterial hypotension, which depends on the extent of vascular obstruction and the previous cardiopulmonary status. Right ventricular dysfunction is an important pathogenic element to define the severity of patients and short term clinical prognosis. The recommended treatment is systemic thrombolysis, but in centers with experience and resources, radiological invasive therapies through catheters are useful alternatives that can be used as first choice tools in certain cases.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.141 n.4 20132013-04-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872013000400010es10.4067/S0034-98872013000400010
institution SCIELO
collection OJS
country Chile
countrycode CL
component Revista
access En linea
databasecode rev-scielo-cl
tag revista
region America del Sur
libraryname SciELO
language Spanish / Castilian
format Digital
author Mercado,Marcelo
Aizman,Andrés
Andresen,Max
spellingShingle Mercado,Marcelo
Aizman,Andrés
Andresen,Max
Controversias en tromboembolismo pulmonar masivo
author_facet Mercado,Marcelo
Aizman,Andrés
Andresen,Max
author_sort Mercado,Marcelo
title Controversias en tromboembolismo pulmonar masivo
title_short Controversias en tromboembolismo pulmonar masivo
title_full Controversias en tromboembolismo pulmonar masivo
title_fullStr Controversias en tromboembolismo pulmonar masivo
title_full_unstemmed Controversias en tromboembolismo pulmonar masivo
title_sort controversias en tromboembolismo pulmonar masivo
description Massive pulmonary embolism (PE) is associated with high mortality. There is still a broad assortment of severity classifications for patients with PE, which affects the choice of therapies to use. The main clinical criteria for defining a PE as massive is systemic arterial hypotension, which depends on the extent of vascular obstruction and the previous cardiopulmonary status. Right ventricular dysfunction is an important pathogenic element to define the severity of patients and short term clinical prognosis. The recommended treatment is systemic thrombolysis, but in centers with experience and resources, radiological invasive therapies through catheters are useful alternatives that can be used as first choice tools in certain cases.
publisher Sociedad Médica de Santiago
publishDate 2013
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872013000400010
work_keys_str_mv AT mercadomarcelo controversiasentromboembolismopulmonarmasivo
AT aizmanandres controversiasentromboembolismopulmonarmasivo
AT andresenmax controversiasentromboembolismopulmonarmasivo
_version_ 1755988420137582592